Kristi Jones
Amministratore Delegato presso NEXIMMUNE, INC.
Patrimonio netto: 8 067 $ in data 30/06/2024
Profilo
Kristi Jones is currently the President, Chief Executive Officer & Director at NexImmune, Inc. She previously worked as the Head-Immunology & Ophthalmology at Genentech, Inc. and as the Vice President-Global Strategic Marketing at MedImmune LLC.
Additionally, she held the position of Vice President-Portfolio Strategy at AstraZeneca, Inc. from 2013 to 2015.
Ms. Jones completed her undergraduate degree at Texas Tech University and Ut College of Pharmacy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NEXIMMUNE, INC.
0.21% | 01/03/2024 | 2 923 ( 0.21% ) | 8 067 $ | 30/06/2024 |
Posizioni attive di Kristi Jones
| Società | Posizione | Inizio |
|---|---|---|
| NEXIMMUNE, INC. | Amministratore Delegato | 15/02/2022 |
Precedenti posizioni note di Kristi Jones
| Società | Posizione | Fine |
|---|---|---|
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | 01/01/2015 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/07/2013 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Kristi Jones
| Ut College of Pharmacy | Undergraduate Degree |
| Texas Tech University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEXIMMUNE, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Kristi Jones
